Other languages ANI Pharmaceuticals, Inc.

Equities

ANIP

US00182C1036

Real-time Estimate Cboe BZX Other stock markets 10:22:37 2024-05-17 am EDT			5-day change	1st Jan Change
63.74 ^USD	-0.05%		-6.54%	+15.34%

May. 16	Ani Pharmaceuticals Insider Sold Shares Worth $1,101,821, According to a Recent SEC Filing	MT
May. 10	ANI Pharmaceuticals Seeks M&A	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ani Pharmaceuticals Insider Sold Shares Worth $1,101,821, According to a Recent SEC Filing	May. 16
ANI Pharmaceuticals Seeks M&A	May. 10
ANI Pharmaceuticals, Inc. Reiterates Earnings Guidance for the Full Year 2024	May. 10
ANI Pharmaceuticals Q1 Adjusted Earnings, Revenue Rise; Reaffirms Full Year 2024 Earnings, Revenue Guidance	May. 10
Futures Rebound Pre-Bell Ahead of Earnings, Next Week's Inflation Reports; Asia, Europe Gain	May. 10
ANI Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 10
Ani Pharmaceuticals Insider Sold Shares Worth $1,332,400, According to a Recent SEC Filing	May. 03
Ani Pharmaceuticals Insider Sold Shares Worth $1,500,589, According to a Recent SEC Filing	Apr. 17
ANI Pharmaceuticals, Inc. Announces the Launch of Baclofen Oral Suspension	Apr. 09
Ani Pharmaceuticals Insider Sold Shares Worth $1,345,000, According to a Recent SEC Filing	Apr. 03
ANI Pharmaceuticals, Inc. Announces the Launch of Levofloxacin Oral Solution, USP	Mar. 27
Ani Pharmaceuticals Insider Sold Shares Worth $671,700, According to a Recent SEC Filing	Mar. 12
Ani Pharmaceuticals Insider Sold Shares Worth $2,630,864, According to a Recent SEC Filing	Mar. 08
Ani Pharmaceuticals Insider Sold Shares Worth $456,400, According to a Recent SEC Filing	Mar. 06
Ani Pharmaceuticals Insider Sold Shares Worth $330,000, According to a Recent SEC Filing	Mar. 06
Sector Update: Health Care Stocks Decline Late Afternoon	Feb. 29
Sector Update: Health Care Stocks Retreat Thursday Afternoon	Feb. 29
ANI Pharmaceuticals Shares Rise After Q4 Adjusted Earnings, Net Revenue Beat Forecasts	Feb. 29
Ani Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 29
ANI Pharmaceuticals, Inc. Provides Earnings Guidance for the Year 2024	Feb. 29

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages ANI Pharmaceuticals, Inc.

Equities

ANIP

US00182C1036

Other languages

Filters